HU179141B - - Google Patents

Info

Publication number
HU179141B
HU179141B HU77CI1770A HUCI001770A HU179141B HU 179141 B HU179141 B HU 179141B HU 77CI1770 A HU77CI1770 A HU 77CI1770A HU CI001770 A HUCI001770 A HU CI001770A HU 179141 B HU179141 B HU 179141B
Authority
HU
Hungary
Application number
HU77CI1770A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to HU77CI1770A priority Critical patent/HU179141B/hu
Priority to IL55569A priority patent/IL55569A/xx
Priority to GR57216A priority patent/GR65001B/el
Priority to DE19782840142 priority patent/DE2840142A1/de
Priority to CS786036A priority patent/CS200242B2/cs
Priority to IT69160/78A priority patent/IT1160661B/it
Priority to YU02206/78A priority patent/YU220678A/xx
Priority to AT0677478A priority patent/AT369362B/de
Priority to BE190613A priority patent/BE870646A/fr
Priority to FI782878A priority patent/FI65912C/fi
Priority to SE7809946A priority patent/SE447574B/sv
Priority to FR7827079A priority patent/FR2404006A1/fr
Priority to DD78208003A priority patent/DD138600A5/xx
Priority to NL7809643A priority patent/NL7809643A/xx
Priority to JP11738378A priority patent/JPS5456685A/ja
Priority to DK420778A priority patent/DK420778A/da
Priority to PL1978209773A priority patent/PL121664B1/pl
Priority to SU782668853A priority patent/SU847914A3/ru
Priority to GB7837834A priority patent/GB2006193B/en
Priority to CH995078A priority patent/CH637388A5/de
Publication of HU179141B publication Critical patent/HU179141B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HU77CI1770A 1977-09-23 1977-09-23 HU179141B (fr)

Priority Applications (20)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (fr) 1977-09-23 1977-09-23
IL55569A IL55569A (en) 1977-09-23 1978-09-13 Inclusion complexes of prostacyclin,or a derivative thereof,with cyclodextrins,their preparation and pharmaceutical compositions containing them
GR57216A GR65001B (en) 1977-09-23 1978-09-13 Method for the preparation of complexes of prostacycline occlusion and derivatives of prostacycline with cyclodextrines
DE19782840142 DE2840142A1 (de) 1977-09-23 1978-09-15 Die mit cyclodextrin gebildeten einschlusskomplexe des prostacyclins und seiner derivate sowie verfahren zur herstellung dieser komplexe
CS786036A CS200242B2 (en) 1977-09-23 1978-09-18 Process for preparing inclusion complexes of derivatives prostacycline with beta-cyclodextrine
IT69160/78A IT1160661B (it) 1977-09-23 1978-09-19 Complessi di inclusione di prostaciclina e derivati di prostaciclina con ciclodestrine e procedimento per la loro preparazione
YU02206/78A YU220678A (en) 1977-09-23 1978-09-19 Process for obtaining inclusion complexes of cyclodextrin with prostacycline
AT0677478A AT369362B (de) 1977-09-23 1978-09-20 Verfahren zur herstellung von neuen cyclodextrin- einschlusskomplexen des prostacyclins und dessen derivaten
BE190613A BE870646A (fr) 1977-09-23 1978-09-21 Complexes d'inclusion de prostacycline et de derives de prostacycline avec des cyclodextrines, leur preparation et leur application comme medicaments
FI782878A FI65912C (fi) 1977-09-23 1978-09-21 Foerfarande foer framstaellning av farmaceutiskt anvaendbara inklusionskomplexer av prostacyklin och prostacyklin-c1-4-estrar med beta-cyklodextrin
SE7809946A SE447574B (sv) 1977-09-23 1978-09-21 Inklusionskomplex av prostacyklin-metylester och beta-cyklodextrin, sett for dess framstellning samt lekemedelsberedning baserad derpa
FR7827079A FR2404006A1 (fr) 1977-09-23 1978-09-21 Complexes d'inclusion de prostacycline et de derives de prostacycline avec des cyclodextrines, leur preparation et leur application comme medicaments
DD78208003A DD138600A5 (de) 1977-09-23 1978-09-21 Verfahren zur herstellung eines mit cyclodextrinen gebildeten prostacyclin-einschlusskomplexes
NL7809643A NL7809643A (nl) 1977-09-23 1978-09-22 Werkwijzen voor het bereiden van insluitingscomplexen en van geneesmiddelen die deze complexen bevatten.
JP11738378A JPS5456685A (en) 1977-09-23 1978-09-22 Cyclodextrineeencloseddtype complex compounds of prostacycline and derivative thereof* and method of making same
DK420778A DK420778A (da) 1977-09-23 1978-09-22 Inklusionskomplekser af prostacyclin og prostacyclinderivatermed cyclodextriner samt deres fremstilling og anvendelse
PL1978209773A PL121664B1 (en) 1977-09-23 1978-09-22 Process for preparing inclusion compounds of prostacycline and its esters with alkyls of 1 to 4 carbon atoms with cyclodextrinsna i ego alkilovykh ehfirov s 1-4 atomami uglja s ciklogekstrinami
SU782668853A SU847914A3 (ru) 1977-09-23 1978-09-22 Способ получени комплексов включени С -циКлОдЕКСТРиНОМ пРОизВОдНыХ пРОСТАциКлиНОВ
GB7837834A GB2006193B (en) 1977-09-23 1978-09-22 Nclusion complexes of prostacyclin and its derivatives their preparation and pharmaceutical compositions containing them
CH995078A CH637388A5 (de) 1977-09-23 1978-09-22 Die mit cyclodextrin gebildeten einschlusskomplexe des prostacyclins und seiner ester sowie verfahren zur herstellung dieser komplexe.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (fr) 1977-09-23 1977-09-23

Publications (1)

Publication Number Publication Date
HU179141B true HU179141B (fr) 1982-08-28

Family

ID=10994670

Family Applications (1)

Application Number Title Priority Date Filing Date
HU77CI1770A HU179141B (fr) 1977-09-23 1977-09-23

Country Status (20)

Country Link
JP (1) JPS5456685A (fr)
AT (1) AT369362B (fr)
BE (1) BE870646A (fr)
CH (1) CH637388A5 (fr)
CS (1) CS200242B2 (fr)
DD (1) DD138600A5 (fr)
DE (1) DE2840142A1 (fr)
DK (1) DK420778A (fr)
FI (1) FI65912C (fr)
FR (1) FR2404006A1 (fr)
GB (1) GB2006193B (fr)
GR (1) GR65001B (fr)
HU (1) HU179141B (fr)
IL (1) IL55569A (fr)
IT (1) IT1160661B (fr)
NL (1) NL7809643A (fr)
PL (1) PL121664B1 (fr)
SE (1) SE447574B (fr)
SU (1) SU847914A3 (fr)
YU (1) YU220678A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
EP1710244A4 (fr) * 2004-01-29 2009-06-17 Eisai R&D Man Co Ltd Methode de stabilisation d un compose de macrolide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (fr) * 1970-06-10 1975-02-04
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds

Also Published As

Publication number Publication date
ATA677478A (de) 1982-05-15
SU847914A3 (ru) 1981-07-15
FI65912B (fi) 1984-04-30
FI65912C (fi) 1984-08-10
NL7809643A (nl) 1979-03-27
FR2404006A1 (fr) 1979-04-20
GR65001B (en) 1980-06-12
SE7809946L (sv) 1979-03-24
YU220678A (en) 1983-10-31
GB2006193B (en) 1982-05-26
GB2006193A (en) 1979-05-02
IT7869160A0 (it) 1978-09-19
JPS5456685A (en) 1979-05-07
IL55569A (en) 1981-12-31
CS200242B2 (en) 1980-08-29
FI782878A (fi) 1979-03-24
SE447574B (sv) 1986-11-24
BE870646A (fr) 1979-01-15
IT1160661B (it) 1987-03-11
IL55569A0 (en) 1978-12-17
CH637388A5 (de) 1983-07-29
DE2840142A1 (de) 1979-04-05
PL209773A1 (pl) 1979-06-04
FR2404006B1 (fr) 1981-07-31
AT369362B (de) 1982-12-27
DK420778A (da) 1979-03-24
PL121664B1 (en) 1982-05-31
DD138600A5 (de) 1979-11-14

Similar Documents

Publication Publication Date Title
FR2389375B1 (fr)
FR2376722B1 (fr)
FR2377191B1 (fr)
AU495917B2 (fr)
AU71461S (fr)
BE851449A (fr)
BE865722A (fr)
BE866391A (fr)
BE868323A (fr)
BE870787A (fr)
BE871419A (fr)
BE871991A (fr)
BE872973A (fr)
BE873002A (fr)
BG23438A1 (fr)
BG23462A1 (fr)
BG24331A1 (fr)
BG24713A1 (fr)
BG25808A1 (fr)
BG25809A1 (fr)
BG25810A1 (fr)
BG25812A1 (fr)
BG25813A1 (fr)
BG25815A1 (fr)
BG25819A1 (fr)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee